Quantamental Technologies’s United Therapeutics UTHR Stock Holding History

Quantamental Technologies’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$496K	Buy	+2,196	New	+$506K	0.47%	74
2022 Q2	–	Sell	-3,312	Closed	-$594K	–	572
2022 Q1	$594K	Buy	+3,312	New	+$631K	0.34%	102
2019 Q4	–	Sell	-2,536	Closed	-$202K	–	1304
2019 Q3	$202K	Sell	2,536 -1,462	-37%	-$118K	0.07%	500
2019 Q2	$312K	Buy	+3,998	New	+$374K	0.12%	288

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Quantamental Technologies's UTHR Position: Q3 2023 in Review

Quantamental Technologies opened a new position in United Therapeutics (UTHR) in Q3 2023: 2,196 shares worth $496K. The stake represents 0.47% of the portfolio and ranks #74 among its holdings. This is a return to the name: Quantamental Technologies previously reported a position in UTHR as recently as Q1 2022.

Quantamental Technologies first reported a position in UTHR in Q2 2019 and has held it in 4 quarters since. The position peaked at $594K in Q1 2022. 508 funds tracked by Wall St. Rank hold UTHR as of Q3 2023.

Quantamental Technologies held 2,196 shares of United Therapeutics worth $496K as of Q3 2023.
United Therapeutics was a new Quantamental Technologies position in Q3 2023.
United Therapeutics made up 0.47% of Quantamental Technologies's portfolio in Q3 2023, its #74 holding.
Quantamental Technologies first reported a position in United Therapeutics in Q2 2019 and has held it in 4 quarters since.
Quantamental Technologies's United Therapeutics position peaked at $594K in Q1 2022.
508 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.